TABLE OF CONTENT: Introduction Research Scope Market Segmentation Research Methodology Definitions and Assumptions Executive Summary Market Dynamics Market Drivers Market Restraints Market Opportunities Key Insights Prevalence/ Incidence, by Cancer Type, by Key Regional/ Countries New Product Launches, by Key Market Players Pipeline Analysis, Cancer Biomarkers Key industry Developments - Mergers, Acquisitions and Partnerships Global Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis, Insights and Forecast – By Cancer Type Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Others Market Analysis, Insights and Forecast – By Biomarker Type PSA HER-2 EGFR KRAS Others Market Analysis, Insights and Forecast – By End User Pharmaceutical & Biotechnology Companies Diagnostics & Research Laboratories Hospitals & Specialty Clinics Others Market Analysis, Insights and Forecast – By Region North America Europe Asia Pacific Latin America Middle East & Africa North America Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis, Insights and Forecast – By Cancer Type Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Others Market Analysis, Insights and Forecast – By Biomarker Type PSA HER-2 EGFR KRAS Others Market Analysis, Insights and Forecast – By End User Pharmaceutical & Biotechnology Companies Diagnostics & Research Laboratories Hospitals & Specialty Clinics Others Market Analysis, Insights and Forecast – By Country/ Sub-region U.S. Canada Europe Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis, Insights and Forecast – By Cancer Type Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Others Market Analysis, Insights and Forecast – By Biomarker Type PSA HER-2 EGFR KRAS Others Market Analysis, Insights and Forecast – By End User Pharmaceutical & Biotechnology Companies Diagnostics & Research Laboratories Hospitals & Specialty Clinics Others Market Analysis, Insights and Forecast – By Country/ Sub-region U.K. Germany France Spain Italy Scandinavia Rest of Europe Asia Pacific Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis, Insights and Forecast – By Cancer Type Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Others Market Analysis, Insights and Forecast – By Biomarker Type PSA HER-2 EGFR KRAS Others Market Analysis, Insights and Forecast – By End User Pharmaceutical & Biotechnology Companies Diagnostics & Research Laboratories Hospitals & Specialty Clinics Others Market Analysis, Insights and Forecast – By Country/ Sub-region Japan China India Australia Southeast Asia Rest of Asia Pacific Latin America Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis, Insights and Forecast – By Cancer Type Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Others Market Analysis, Insights and Forecast – By Biomarker Type PSA HER-2 EGFR KRAS Others Market Analysis, Insights and Forecast – By End User Pharmaceutical & Biotechnology Companies Diagnostics & Research Laboratories Hospitals & Specialty Clinics Others Market Analysis, Insights and Forecast – By Country/ Sub-region Brazil Mexico Rest of Latin America Middle East & Africa Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis, Insights and Forecast – By Cancer Type Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Others Market Analysis, Insights and Forecast – By Biomarker Type PSA HER-2 EGFR KRAS Others Market Analysis, Insights and Forecast – By End User Pharmaceutical & Biotechnology Companies Diagnostics & Research Laboratories Hospitals & Specialty Clinics Others Market Analysis, Insights and Forecast – By Country/ Sub-region GCC Countries South Africa Rest of Middle East & Africa Competitive Analysis Key Industry Developments Global Market Share Analysis (2018) Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) F. Hoffmann-La Roche Ltd. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Abbott Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) CENTOGENE N.V. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Bio-Rad Laboratories, Inc. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) CENTOGENE N.V. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Axon Medchem Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Sino Biological Inc. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) R&D System Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) BioVision Inc. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Myriad RBM Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Other Prominent Players Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Strategic Recommendation

LIST OF KEY COMPANIES PROFILED: F. Hoffmann-La Roche Ltd. Abbott Thermo Fisher Scientific Bio-Rad Laboratories, Inc. CENTOGENE N.V. Axon Medchem Sino Biological Inc. R&D System BioVision Inc. Myriad RBM Other players